LEI110 treatment transcriptionally suppressed NUDT1, PARP1, TOP2A, and POLD1 expression at 24 h–48 h (Fig. 4d) and induced the accumulation of oxidized DNA lesions in HCC cells (Fig. 4e). The gene discussed is POLD1; the disease is hepatocellular carcinoma.